DE602005023600D1 - Substituierte 1-phenyl-1,5-dihydro-pyridoä3,2-büindol-2-on-derivate verwendbar als pharmazeutische antiinfektiva - Google Patents

Substituierte 1-phenyl-1,5-dihydro-pyridoä3,2-büindol-2-on-derivate verwendbar als pharmazeutische antiinfektiva

Info

Publication number
DE602005023600D1
DE602005023600D1 DE602005023600T DE602005023600T DE602005023600D1 DE 602005023600 D1 DE602005023600 D1 DE 602005023600D1 DE 602005023600 T DE602005023600 T DE 602005023600T DE 602005023600 T DE602005023600 T DE 602005023600T DE 602005023600 D1 DE602005023600 D1 DE 602005023600D1
Authority
DE
Germany
Prior art keywords
pyridoä3
büindol
infectives
dihydro
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005023600T
Other languages
English (en)
Inventor
Bart Rudolf Kesteleyn
Sandrine Marie Vendeville
Natalie Maria Kindermans
Dominique Louis Surleraux
Pierre Jean-Marie Bernard Raboisson
Piet Tom Wigerinck
Annick Ann Peeters
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LITTLE ISLAND CO CORK
Original Assignee
LITTLE ISLAND CO CORK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LITTLE ISLAND CO CORK filed Critical LITTLE ISLAND CO CORK
Publication of DE602005023600D1 publication Critical patent/DE602005023600D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE602005023600T 2004-05-17 2005-05-17 Substituierte 1-phenyl-1,5-dihydro-pyridoä3,2-büindol-2-on-derivate verwendbar als pharmazeutische antiinfektiva Active DE602005023600D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04102170 2004-05-17
PCT/EP2005/052263 WO2005111035A1 (en) 2004-05-17 2005-05-17 6,7,8,9-substituted 1-phenyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones useful as anti-infective pharmaceutical agents

Publications (1)

Publication Number Publication Date
DE602005023600D1 true DE602005023600D1 (de) 2010-10-28

Family

ID=34929105

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005023600T Active DE602005023600D1 (de) 2004-05-17 2005-05-17 Substituierte 1-phenyl-1,5-dihydro-pyridoä3,2-büindol-2-on-derivate verwendbar als pharmazeutische antiinfektiva

Country Status (14)

Country Link
US (2) US7622581B2 (de)
EP (1) EP1751156B1 (de)
JP (1) JP2007538050A (de)
CN (1) CN1976930B (de)
AR (1) AR049637A1 (de)
AT (1) ATE481403T1 (de)
BR (1) BRPI0511173A (de)
DE (1) DE602005023600D1 (de)
ES (1) ES2351702T3 (de)
MX (1) MXPA06013313A (de)
PL (1) PL1751156T3 (de)
RU (1) RU2377243C2 (de)
TW (1) TW200607502A (de)
WO (1) WO2005111035A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007113290A1 (en) 2006-04-03 2007-10-11 Tibotec Pharmaceuticals Ltd. Hiv inhibiting 3,4-dihydro-imidazo[4,5-b]pyridin-5-ones
WO2008037783A1 (en) * 2006-09-29 2008-04-03 Tibotec Pharmaceuticals Ltd. Process for preparing 2-oxo-2,5-dihydro-1h-pyrido[3,2-b]indole-3-carbonitriles
MX2011010582A (es) 2009-04-09 2011-10-19 Boehringer Ingelheim Int Inhibidores de la replicacion del vih.
JP2013526496A (ja) * 2010-05-14 2013-06-24 アフェクティス ファーマシューティカルズ アーゲー Ｐ２ｘ７ｒ拮抗剤の新規調製方法
RU2451680C1 (ru) 2011-02-21 2012-05-27 Общество С Ограниченной Ответственностью "Научно-Исследовательская Компания "Медбиофарм" Клатратный комплекс циклодекстрина или арабиногалактана с 9-фенил-симм-октагидроселеноксантеном, способ его получения (варианты), фармацевтическая композиция и лекарственное средство
RU2464042C1 (ru) * 2011-03-31 2012-10-20 Общество С Ограниченной Ответственностью "Научно-Исследовательская Компания "Медбиофарм" КЛАТРАТНЫЙ КОМПЛЕКС β-ЦИКЛОДЕКСТРИНА С ПРОИЗВОДНЫМ 5-ГИДРОКСИ-4-АМИНОМЕТИЛ-1-ЦИКЛОГЕКСИЛ(ИЛИ ЦИКЛОГЕПТИЛ)-3-АЛКОКСИКАРБОНИЛИНДОЛА, СПОСОБ ЕГО ПОЛУЧЕНИЯ (ВАРИАНТЫ), ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И ЛЕКАРСТВЕННОЕ СРЕДСТВО
WO2013037705A2 (en) 2011-09-16 2013-03-21 Fovea Pharmaceuticals Aniline derivatives,their preparation and their therapeutic application
RU2640081C1 (ru) * 2016-07-11 2017-12-26 Общество с ограниченной ответственностью "ЛАЙФ САЙНСЕС ОХФК" Фармацевтическая композиция и лекарственное средство на основе клатратного комплекса N-карбамоилметил-4-фенил-2-пирролидон или 4-фенилпирацетам с циклодекстрином, способы его получения (варианты)
WO2019180369A1 (fr) * 2018-03-20 2019-09-26 Compagnie Generale Des Etablissements Michelin Câblé textile aramide perfectionne à au moins triple torsion
CN108530381B (zh) * 2018-05-07 2021-09-21 上海科技大学 一种由酰胺酯制备二胺衍生物的方法
WO2022212471A1 (en) * 2021-03-31 2022-10-06 Virginia Commonwealth University Bivalent ligands to understand dimerization of the mu opioid receptor and the chemokine receptor ccr5 in neurological disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB427857A (en) 1934-08-02 1935-05-01 Newsum Sons & Company Ltd H A new or improved system of construction for skeleton structures, particularly vehicle body frames and door frames
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
WO1995009615A1 (en) 1993-10-01 1995-04-13 Astra Aktiebolag Process i
WO1997044014A1 (en) 1996-05-20 1997-11-27 Janssen Pharmaceutica N.V. Antifungal compositions with improved bioavailability
CZ295502B6 (cs) 1997-03-26 2005-08-17 Janssen Pharmaceutica N. V. Antifungální peleta, způsob její přípravy a farmaceutická dávková forma s obsahem těchto pelet
AU2002246659A1 (en) 2000-12-18 2002-08-06 The Government Of The United States Of America, As Represented By The Secretary, Department Of Healt Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
WO2002055520A2 (en) * 2000-12-18 2002-07-18 Us Health Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
ES2278064T3 (es) * 2001-10-19 2007-08-01 Transtech Pharma Inc. Derivados de beta-carbolina como inhibidores de ptp.
MXPA05005146A (es) 2002-11-15 2005-07-22 Tibotec Pharm Ltd Indolpiridinio sustituido como compuestos antiinfecciosos.

Also Published As

Publication number Publication date
RU2377243C2 (ru) 2009-12-27
EP1751156A1 (de) 2007-02-14
EP1751156B1 (de) 2010-09-15
TW200607502A (en) 2006-03-01
JP2007538050A (ja) 2007-12-27
ES2351702T3 (es) 2011-02-09
CN1976930A (zh) 2007-06-06
US7622581B2 (en) 2009-11-24
ATE481403T1 (de) 2010-10-15
US20070167434A1 (en) 2007-07-19
CN1976930B (zh) 2011-01-19
AR049637A1 (es) 2006-08-23
RU2006144852A (ru) 2008-06-27
PL1751156T3 (pl) 2011-03-31
WO2005111035A1 (en) 2005-11-24
MXPA06013313A (es) 2007-02-02
US20100029635A1 (en) 2010-02-04
BRPI0511173A (pt) 2007-12-04

Similar Documents

Publication Publication Date Title
DE602005023600D1 (de) Substituierte 1-phenyl-1,5-dihydro-pyridoä3,2-büindol-2-on-derivate verwendbar als pharmazeutische antiinfektiva
DE602004015724D1 (de) Diazepinoindolderivate als kinaseinhibitoren
DE602004024420D1 (de) Chinazolinderivate als antitumormittel
IS8578A (is) 3- karbamoýl - 2- pýridón afleiður
ATE415400T1 (de) Pyrazolopyridinderivate
ATE383361T1 (de) Pyrrazolopyrimidinderivate
ATE394399T1 (de) Tetrahydropyridoindolderivate
ATE540935T1 (de) Chinazolinderivate
IL191907A0 (en) Azepinoindole derivatives as pharmaceutical agents
SMP200800029B (it) 2-ammino-7,8-diidro-6h-pirido[4,3-d]pirimidin-5-oni
NL2000323A1 (nl) Pyrimidine-derivaten.
ATE477257T1 (de) Piperidinylamino-thienoä2,3-dü- pyrimidinverbindungen
DE602006016566D1 (de) Als antikoagulanzien verwendbare phenylglycinamid-derivate
DE602005018190D1 (de) Als modulatoren des dopamin-d3-rezeptors geeignete azabicycloä3.1.0ühexanderivate
ATE417830T1 (de) Sulfonylbenzimidazolderivate
DK1753764T3 (da) Pyrrolopyridin-derivater
ATE487718T1 (de) Substituierte bizyklische pyrimidonderivate
NL2000336A1 (nl) Spirocyclische derivaten.
ATE430142T1 (de) Phenylpiperazin-methanon-derivate
ATE404542T1 (de) 4-phenylpyrimidin-2-carbonitrilderivate
NL2000937A1 (nl) Piperidinederivaten.
DE602006018645D1 (de) 3-monosubstituiertes tropan-derivat als nociceptinrezeptor-ligand
ATE435865T1 (de) Als pde5-inhibitoren verwendete pyrazoloä4,3- düpyrimidin-5-ylderivate
ATE365731T1 (de) 4-amino-5-cyanopyrimidinderivate
ATE394372T1 (de) G-lactamderivate als prostaglandinagonisten